8月27日 - ** 医疗科技公司Veeva Systems（VEEV.N）的股价在盘前交易中上涨逾7%，至264.19美元
** 该公司公布第二季度营收为9.2796亿美元，高于9.0528亿美元的预期；调整后每股收益为2.35美元，高于
2.22美元
** 30家券商中有21家给予该股“买入”或更高评级，8家给予“持有”评级，1家给予“卖出”评级；目标价中位数为295美元——LSEG数据
** 截至前一交易日收盘，该股年内累计涨幅达9.7%
8月27日 - ** 医疗科技公司Veeva Systems（VEEV.N）的股价在盘前交易中上涨逾7%，至264.19美元
** 该公司公布第二季度营收为9.2796亿美元，高于9.0528亿美元的预期；调整后每股收益为2.35美元，高于
2.22美元
** 30家券商中有21家给予该股“买入”或更高评级，8家给予“持有”评级，1家给予“卖出”评级；目标价中位数为295美元——LSEG数据
** 截至前一交易日收盘，该股年内累计涨幅达9.7%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.